The global hematology analyzers & reagents market size is expected to reach USD 16.84 Billion in 2032 and register a steady revenue CAGR of 6.9% during the forecast period, according to latest analysis by Emergen Research. Technological advancements in hematology analyzers and reagents is a major factor driving market revenue growth. One of the fundamental techniques for cell counting that has been used by numerous analyzers is hydrodynamic focusing, which is now available with double power, making counting more dependable and precise. In comparison to earlier conventional focusing approaches, novel Double Hydrodynamic Sequential System (DHSS) offers more consistent and superior outcomes. This technology has good potential with its great resolution and precise quantification of aberrant cells. Utilizing criteria, such as Atypical Lymphocytes (ALY) and Large Immature Cells (LIC), which are useful in diagnosis and distinction of many blood diseases, is made possible by use of DHSS technology. https://www.emergenresearch.com/industry-report/hematology-analyzers-and-reagents-market